Wells Fargo’s Peak Bio, Inc. Common Stock PKBO Stock Holding History

Wells Fargo’s Portfolio PKBO Stock Details PKBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-49	Closed	-$205	–	7915
2022 Q4	$205	Buy	+49	New	+$340	﹤0.01%	6617

Other funds holding PKBO

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Wells Fargo's PKBO Position: Q1 2023 in Review

Wells Fargo sold out of Peak Bio, Inc. Common Stock (PKBO) in Q1 2023, closing a stake of 49 shares — an estimated $205 sold.

Wells Fargo first reported a position in PKBO in Q4 2022 and held it in 1 quarter. The position peaked at $205 in Q4 2022. 1 fund tracked by Wall St. Rank holds PKBO as of Q1 2023.

Wells Fargo reported no remaining Peak Bio, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Wells Fargo sold 49 Peak Bio, Inc. Common Stock shares in Q1 2023, an estimated $205.
Wells Fargo first reported a position in Peak Bio, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
Wells Fargo's Peak Bio, Inc. Common Stock position peaked at $205 in Q4 2022.
1 fund tracked by Wall St. Rank held Peak Bio, Inc. Common Stock as of Q1 2023.

Based on Wells Fargo's 13F filing for Q1 2023, filed 12 May 2023.